Joern M. Schattenberg is a Professor of Medicine and Director of the Department of Medicine II at the Saarland University Medical Center in Homburg, Germany. He received his medical degree in 2002 from the University of Mainz and Tulane University (New Orleans), and completed post-doctoral training at the Albert-Einstein College of Medicine, New York, focusing on signalling pathways in metabolic dysfunction associated steatotic liver disease (MASLD).

Board-certified in Internal Medicine, Gastroenterology & Hepatology, and Infectious Disease, his research focuses on translational sciences and clinical trials in Hepatology. He is involved in multinational EU-funded research consortia on prevention, screening, and treatment of metabolic liver disease. Professor Schattenberg is chair of the UEG scientific committee and Associate Editor of JHEP Reports.